Elevated chromogranin A (CgA) serum levels in the patients with advanced pancreatic cancer
- 30 April 2009
- journal article
- Published by Elsevier BV in Archives of Gerontology and Geriatrics
- Vol. 48 (2), 213-217
- https://doi.org/10.1016/j.archger.2008.01.014
Abstract
No abstract availableKeywords
This publication has 43 references indexed in Scilit:
- Prognostic value of plasma chromogranin A levels in patients with complicated myocardial infarctionAmerican Heart Journal, 2006
- Somatostatin receptor subtype 2 sensitizes human pancreatic cancer cells to death ligand-induced apoptosisProceedings of the National Academy of Sciences of the United States of America, 2002
- Chromogranin A in heart failure. A novel neurohumoral factor and a predictor for mortalityPublished by Oxford University Press (OUP) ,2002
- SOM230: a novel somatostatin peptidomimetic with broad somatotropin release inhibiting factor (SRIF) receptor binding and a unique antisecretory profileActa Endocrinologica, 2002
- Neuroendocrine tumours in various organ systems in a ten-year periodEuropean Journal of Surgical Oncology, 1995
- Revised classification of neuroendocrine tumours of the lung, pancreas and gutVirchows Archiv, 1995
- Chromogranin A: Its Role in Endocrine Function and as an Endocrine and Neuroendocrine Tumor Marker*Endocrine Reviews, 1991
- Histogenesis of pancreatic carcinomas: A study based on 248 casesThe Journal of Pathology, 1985
- Monoclonal antibodies in cell‐mediated cytotoxicity against human melanoma and colorectal carcinomaEuropean Journal of Immunology, 1979
- Mucinous Cystic Neoplasms of the Pancreas with Overt and Latent Malignancy (Cystadenocarcinoma and Cystadenoma): A Clinicopathologic Study of 41 CasesAmerican Journal of Clinical Pathology, 1978